These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8831427)

  • 41. The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery.
    Elmalky M; Yasin N; Rodrigues-Pinto R; Stephenson J; Carroll C; Smurthwaite G; Verma R; Mohammad S; Siddique I
    Spine J; 2017 Jul; 17(7):977-982. PubMed ID: 28323241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic evaluation of cell salvage in pediatric surgery.
    Samnaliev M; Tran CM; Sloan SR; Gasior I; Lightdale JR; Brustowicz RM
    Paediatr Anaesth; 2013 Nov; 23(11):1027-34. PubMed ID: 23952976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Autologous blood transfusion: results with routine use of autologous blood transfusion, normovolemic hemodilution and postoperative retransfusion of drainage blood salvaged with the Solcotrans system].
    Lagana S; Cattaneo F; Hackenbruch W
    Swiss Surg; 1996; 2(6):244-51. PubMed ID: 8998634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risks, options, and informed consent for blood transfusion in elective surgery.
    Goodnough LT; Shuck JM
    Am J Surg; 1990 Jun; 159(6):602-9. PubMed ID: 2112343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
    Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
    Am J Med; 1996 Aug; 101(2A):22S-27S. PubMed ID: 8928704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythropoietic therapy: cost efficiency and reimbursement.
    Jaspan D
    Am J Health Syst Pharm; 2007 Aug; 64(16 Suppl 11):S19-29. PubMed ID: 17687067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intraoperative autologous transfusion.
    Popovsky MA; Devine PA; Taswell HF
    Mayo Clin Proc; 1985 Feb; 60(2):125-34. PubMed ID: 3919219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pro: autologous blood should be available for elective cardiac surgery.
    Spiess BD
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):231-7. PubMed ID: 8204816
    [No Abstract]   [Full Text] [Related]  

  • 49. [When, in which patients and for what surgical procedures should programmed autologous transfusion be considered? Which quantitative benefit should be expected?].
    Laxenaire MC; Boileau S
    Ann Fr Anesth Reanim; 1995; 14 Suppl 1():32-8. PubMed ID: 7486316
    [No Abstract]   [Full Text] [Related]  

  • 50. Autotransfusion in cardiac surgery.
    Cross MH
    Perfusion; 2001 Sep; 16(5):391-400. PubMed ID: 11565894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. When is it safe to operate following myocardial infarction?
    Stafford JA; Drusin RE; Lalwani AK
    Laryngoscope; 2016 Feb; 126(2):299-301. PubMed ID: 26344928
    [No Abstract]   [Full Text] [Related]  

  • 52. Perioperative autologous transfusion service: a logical extension of our role in the operating room.
    Green DM
    Anesthesiology; 1997 Jan; 86(1):258. PubMed ID: 9009962
    [No Abstract]   [Full Text] [Related]  

  • 53. [The donation of autologous blood in pregnancy. Observations on its safety and the cost-benefit relationship].
    Pregazzi R; Levi D'Ancona R; Ricci G; Lui A; Maso G; Parco S; Piunti R
    Minerva Ginecol; 1994 Mar; 46(3):95-8. PubMed ID: 8015706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell salvage during coronary artery bypass surgery and allogenic blood exposure.
    Al-Mandhari S; Maddali MM; Al-Bahrani MJ
    Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):913-6. PubMed ID: 26113735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Erythrocyte reactions and anemic syndromes in patients with myocardial infarct].
    Krylov AA; Frumkin BZ; Shitov IuN
    Kardiologiia; 1974 Oct; 14(10):136-7. PubMed ID: 4444110
    [No Abstract]   [Full Text] [Related]  

  • 56. [Preoperative autologous blood donation--analysis of side effects and complications].
    Schmidt S; Müller N
    Beitr Infusionsther; 1991; 28():307-9. PubMed ID: 1725643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant human erythropoietin therapy in the surgical setting and applications in oncology.
    Goodnough LT
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):98-102. PubMed ID: 1928088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Role of autologous transfusion in economy measures for blood in surgery].
    Janvier G; Bénillan N; Roth C
    Nouv Rev Fr Hematol (1978); 1995; 37 Suppl 1():S5-7. PubMed ID: 7478984
    [No Abstract]   [Full Text] [Related]  

  • 59. Iron therapy after cardiac operation: one prescription less?
    Del Campo C; Lukman H; Mehta H; McKenzie FN
    J Thorac Cardiovasc Surg; 1982 Oct; 84(4):631-3. PubMed ID: 7121050
    [No Abstract]   [Full Text] [Related]  

  • 60. Autologous versus allogeneic transfusion: patients' perceptions and experiences.
    Graham ID; Fergusson D; Dokainish H; Biggs J; McAuley L; Laupacis A
    CMAJ; 1999 Apr; 160(7):989-95. PubMed ID: 10207337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.